Obtained Class 1 Innovative Drug Long-acting Anti-IL-4Ra Monoclonal Antibody MG-K10 . SHENZHEN, CHINA, Jan 24, 2025 - (ACN News ...

Department of Medicinal Chemistry, University of Utah, Salt Lake City, Utah 84112 United States Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, Utah 84112, United States ...

China Medical System Holdings Limited (the "Company", together with its subsidiaries, the "Group" or "CMS") is pleased to announce that on 24 January ...

There were an estimated 263 million cases reported by the World Health Organization in 2023, up from about 248 million cases ...

Anti-IL-4Rα monoclonal antibodies are among the best-selling biologics in this field. MG-K10 is an innovative long-acting anti-IL-4Rα humanized monoclonal antibody that simultaneously blocks the ...

Peptide antigen-associated IgG levels were significantly lower in drug-naïve patients with first episode psychosis compared to control individuals.

Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual ...

IPH4502 is a novel and differentiated topoisomerase I inhibitor ADC designed to precisely target Nectin-4, a cell adhesion ...

Anti-CCP antibodies were analysed by an enzyme immunoassay (EIA). Rheumatoid factors (RFs) were analysed by latex agglutination and two isotype-specific (IgM and IgA) EIAs. Disease activity was ...

A mathematical model suggests that existing HPA-targeting drugs failed in clinical trials for mood disorders because the ...

Anti-malarial antibodies work by binding to the sporozoite ... "Current protective drugs have to be taken every month, whereas the antibody could be given as rarely as once per season," Donini ...